Clinical Trial

Buspirone for Anxiety in Autistic Youth

Name: Buspirone for Anxiety in Autistic Youth — clinical trial record (NCT07439042)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of the study is to do a preliminary trial to determine if buspirone is effective, safe, and tolerable in autistic youth with anxiety.

Trial Details

NCT Number	NCT07439042
Lead Sponsor	Massachusetts General Hospital
Conditions	Anxiety, Autism Spectrum Disorder
Enrollment	20 participants
Start Date	2026-08
Primary Completion	2029-02 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2026-02-27